FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Loxapine Capsules
Status: Currently in Shortage
»Date first posted: 11/25/2019
»Therapeutic Categories: Psychiatry

Expand all

Lannett Company, Inc. (Revised 04/02/2021)

Company Contact Information:
215-333-9000 ext. 4

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg, 100 count bottle (NDC 0527-1394-01) Unavailable. Additional lots are scheduled for release in the April/May timeframe. Product will be made available as it is released (allocating inventory). Manufacturing capacity constraint Other
5 mg, 1000 count bottle (NDC 0527-1394-10) Unavailable

Link to Discontinuance

Discontinuation of the manufacture of the drug
10 mg, 100 count bottle (NDC 0527-1395-01) Allocating Inventory. Additional lots are scheduled for release in the April/May timeframe. Product will be made available as it is released (allocating inventory). Manufacturing capacity constraint Other
10 mg, 1000 count bottle (NDC 0527-1395-10) Unavailable

Link to Discontinuance

Discontinuation of the manufacture of the drug
25 mg, 100 count bottle (NDC 0527-1396-01) Unavailable. Additional lots are scheduled for release in the April/May timeframe. Product will be made available as it is released (allocating inventory). Manufacturing capacity constraint Other
25 mg, 1000 count bottle (NDC 0527-1396-10) Unavailable

Link to Discontinuance

Discontinuation of the manufacture of the drug
50 mg, 100 count bottle (NDC 0527-1397-01) Allocating Inventory. Additional lots are scheduled for release in the April/May timeframe. Product will be made available as it is released (allocating inventory). Manufacturing capacity constraint Other
50 mg, 1000 count bottle (NDC 0527-1397-10) Unavailable

Link to Discontinuance

Discontinuation of the manufacture of the drug

Mylan Pharmaceuticals Inc. (Reverified 04/13/2021)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg, 100 count bottle (NDC 0378-7005-01) Unavailable. Re-supply TBD. Other
10 mg, 100 count bottle (NDC 0378-7010-01) Unavailable. Re-supply TBD. Other
25 mg, 100 count bottle (NDC 0378-7025-01) Unavailable. Re-supply TBD. Other
50 mg, 100 count bottle (NDC 0378-7050-01) Unavailable. Re-supply TBD. Other

Teva Pharmaceuticals (Reverified 04/13/2021)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
5 mg, 100 count bottle (NDC 0591-0369-01) Available Cannot support additional business currently. Other
10 mg, 100 count bottle (NDC 0591-0370-01) Available Cannot support additional business currently. Other
25 mg, 100 count bottle (NDC 0591-0371-01) Available Cannot support additional business currently. Other
50 mg, 100 count bottle (NDC 0591-0372-01) Available Cannot support additional business currently. Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English